{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T06:29:47Z","timestamp":1790836187939,"version":"4.1.0"},"reference-count":162,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001501","name":"University Grants Commission","doi-asserted-by":"publisher","award":["211610018484"],"award-info":[{"award-number":["211610018484"]}],"id":[{"id":"10.13039\/501100001501","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Hazardous Materials"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.jhazmat.2024.135087","type":"journal-article","created":{"date-parts":[[2024,7,2]],"date-time":"2024-07-02T17:48:58Z","timestamp":1719942538000},"page":"135087","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Hazards of antiviral contamination in water: Dissemination, fate, risk and their impact on fish"],"prefix":"10.1016","volume":"476","author":[{"given":"Abhigyan","family":"Choudhury","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Probir Kumar","family":"Ojha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sajal","family":"Ray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1527","key":"10.1016\/j.jhazmat.2024.135087_bib1","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1098\/rstb.2009.0036","article-title":"The not so universal tree of life or the place of viruses in the living world","volume":"364","author":"Br\u00fcssow","year":"2009","journal-title":"Philos Trans R Soc B: Biol Sci"},{"key":"10.1016\/j.jhazmat.2024.135087_bib2","unstructured":"World Health Organization. (25th March, 2024). WHO COVID-19 dashboard. \u3008https:\/\/data.who.int\/dashboards\/covid19\/cases\u3009."},{"issue":"2","key":"10.1016\/j.jhazmat.2024.135087_bib3","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1007\/s11270-012-1410-3","article-title":"Occurrence and removal of antiviral drugs in environment: a review","volume":"224","author":"Jain","year":"2013","journal-title":"Water, Air, Soil Pollut"},{"key":"10.1016\/j.jhazmat.2024.135087_bib4","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.jchromb.2015.03.008","article-title":"Development of a SPE-HPLC\u2013MS\/MS method for the determination of most prescribed pharmaceuticals and related metabolites in urban sewage samples","volume":"990","author":"Gurke","year":"2015","journal-title":"J Chromatogr B"},{"issue":"3","key":"10.1016\/j.jhazmat.2024.135087_bib5","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1007\/s10311-022-01491-0","article-title":"Waves of pharmaceutical waste","volume":"21","author":"Han","year":"2023","journal-title":"Environ Chem Lett"},{"issue":"5","key":"10.1016\/j.jhazmat.2024.135087_bib6","article-title":"Predicting adverse side effects of drugs","volume":"12","author":"Huang","year":"2011","journal-title":"BMC Genom"},{"key":"10.1016\/j.jhazmat.2024.135087_bib7","unstructured":"Food and Agriculture Organization of the United Nations. The state of world fisheries and aquaculture 2022a. Total fisheries and aquaculture production. \u3008https:\/\/www.fao.org\/3\/cc0461en\/online\/sofia\/2022\/world-fisheries-aquaculture-production.html\u3009."},{"key":"10.1016\/j.jhazmat.2024.135087_bib8","unstructured":"Food and Agriculture Organization of the United Nations. The state of world fisheries and aquaculture 2022b. Aquaculture production. \u3008https:\/\/www.fao.org\/3\/cc0461en\/online\/sofia\/2022\/aquaculture-production.html\u3009."},{"key":"10.1016\/j.jhazmat.2024.135087_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.jwpe.2022.103036","article-title":"A sustainable approach for the removal methods and analytical determination methods of antiviral drugs from water\/wastewater: a review","volume":"49","author":"Eryildiz","year":"2022","journal-title":"J Water Process Eng"},{"issue":"2","key":"10.1016\/j.jhazmat.2024.135087_bib10","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1007\/s10311-021-01356-y","article-title":"COVID-19 drugs in aquatic systems: a review","volume":"20","author":"Gwenzi","year":"2022","journal-title":"Environ Chem Lett"},{"issue":"5","key":"10.1016\/j.jhazmat.2024.135087_bib11","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.3390\/w12051376","article-title":"Contamination of surface water and river sediments by antibiotic and antiretroviral drug cocktails in low and middle-income countries: occurrence, risk and mitigation strategies","volume":"12","author":"Kairigo","year":"2020","journal-title":"Water"},{"key":"10.1016\/j.jhazmat.2024.135087_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.scitotenv.2019.134322","article-title":"Antiviral drugs in aquatic environment and wastewater treatment plants: a review on occurrence, fate, removal and ecotoxicity","volume":"699","author":"Nannou","year":"2020","journal-title":"Sci Total Environ"},{"key":"10.1016\/j.jhazmat.2024.135087_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.envres.2020.109808","article-title":"Current emerging SARS-CoV-2 pandemic: potential direct\/indirect negative impacts of virus persistence and related therapeutic drugs on the aquatic compartments","volume":"188","author":"Race","year":"2020","journal-title":"Environ Res"},{"key":"10.1016\/j.jhazmat.2024.135087_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhazmat.2023.131694","article-title":"Antiviral drugs in wastewater are on the rise as emerging contaminants: a comprehensive review of spatiotemporal characteristics, removal technologies and environmental risks","volume":"457","author":"Wang","year":"2023","journal-title":"J Hazard Mater"},{"key":"10.1016\/j.jhazmat.2024.135087_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.watres.2021.117803","article-title":"Occurrence, removal and mass loads of antiviral drugs in seven wastewater treatment plants with various treatment processes","volume":"207","author":"Yao","year":"2021","journal-title":"Water Res"},{"issue":"3","key":"10.1016\/j.jhazmat.2024.135087_bib16","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1128\/JVI.02046-13","article-title":"DNA virus replication compartments","volume":"88","author":"Schmid","year":"2014","journal-title":"J Virol"},{"issue":"2","key":"10.1016\/j.jhazmat.2024.135087_bib17","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1574-6976.2008.00132.x","article-title":"RNA viruses in the sea","volume":"33","author":"Lang","year":"2009","journal-title":"FEMS Microbiol Rev"},{"key":"10.1016\/j.jhazmat.2024.135087_bib18","series-title":"Viruses","first-page":"97","article-title":"Chapter 10 - Introduction to RNA Viruses","author":"Payne","year":"2017"},{"key":"10.1016\/j.jhazmat.2024.135087_bib19","series-title":"Molecular Virology of Human Pathogenic Viruses","first-page":"31","article-title":"Chapter 3 - Virus Life Cycle","author":"Ryu","year":"2017"},{"issue":"5","key":"10.1016\/j.jhazmat.2024.135087_bib20","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/s00232-020-00136-z","article-title":"Entry inhibitors: efficient means to block viral infection","volume":"253","author":"Pattnaik","year":"2020","journal-title":"J Membr Biol"},{"key":"10.1016\/j.jhazmat.2024.135087_bib21","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.coviro.2020.07.001","article-title":"Viral structural proteins as targets for antivirals","volume":"45","author":"Schlicksup","year":"2020","journal-title":"Curr Opin Virol"},{"issue":"1","key":"10.1016\/j.jhazmat.2024.135087_bib22","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.virusres.2008.01.003","article-title":"Novel HIV-1 reverse transcriptase inhibitors","volume":"134","author":"Jochmans","year":"2008","journal-title":"Virus Res"},{"issue":"4","key":"10.1016\/j.jhazmat.2024.135087_bib23","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1016\/j.apsb.2021.11.009","article-title":"Approved HIV reverse transcriptase inhibitors in the past decade","volume":"12","author":"Li","year":"2022","journal-title":"Acta Pharm Sin B"},{"issue":"6479","key":"10.1016\/j.jhazmat.2024.135087_bib24","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1126\/science.aay4919","article-title":"Structural basis of second-generation HIV integrase inhibitor action and viral resistance","volume":"367","author":"Cook","year":"2020","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.jhazmat.2024.135087_bib25","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1128\/JVI.01534-07","article-title":"Broad antiretroviral activity and resistance profile of the novel human immunodeficiency virus integrase inhibitor elvitegravir (JTK-303\/GS-9137)","volume":"82","author":"Shimura","year":"2008","journal-title":"J Virol"},{"issue":"8","key":"10.1016\/j.jhazmat.2024.135087_bib26","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1111\/j.1365-2893.2010.01315.x","article-title":"Control of hepatitis B virus at the level of transcription","volume":"17","author":"Quasdorff","year":"2010","journal-title":"J Viral Hepat"},{"key":"10.1016\/j.jhazmat.2024.135087_bib27","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1068449","article-title":"Protein post-translational modification in SARS-CoV-2 and host interaction [Review]","volume":"13","author":"Cheng","year":"2023","journal-title":"Front Immunol"},{"issue":"43","key":"10.1016\/j.jhazmat.2024.135087_bib28","doi-asserted-by":"crossref","first-page":"29798","DOI":"10.1074\/jbc.M109.029470","article-title":"Thiazolides, a new class of anti-influenza molecules targeting viral hemagglutinin at the post-translational level","volume":"284","author":"Rossignol","year":"2009","journal-title":"J Biol Chem"},{"issue":"4","key":"10.1016\/j.jhazmat.2024.135087_bib29","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1002\/bip.22780","article-title":"New directions for protease inhibitors directed drug discovery","volume":"106","author":"Hamada","year":"2016","journal-title":"Pept Sci"},{"issue":"1","key":"10.1016\/j.jhazmat.2024.135087_bib30","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.0040036","article-title":"A novel substrate-based HIV-1 protease inhibitor drug resistance mechanism","volume":"4","author":"Nijhuis","year":"2007","journal-title":"PLoS Med"},{"issue":"2","key":"10.1016\/j.jhazmat.2024.135087_bib31","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1128\/jvi.68.2.1103-1114.1994","article-title":"Assembly of vaccinia virus: effects of rifampin on the intracellular distribution of viral protein p65","volume":"68","author":"Sodeik","year":"1994","journal-title":"J Virol"},{"issue":"1","key":"10.1016\/j.jhazmat.2024.135087_bib32","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1345\/aph.10118","article-title":"Neuraminidase inhibitors: zanamivir and oseltamivir","volume":"35","author":"McNicholl","year":"2001","journal-title":"Ann Pharmacother"},{"issue":"9","key":"10.1016\/j.jhazmat.2024.135087_bib33","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1002\/cmdc.201200155","article-title":"Recent advances in neuraminidase inhibitor development as anti-influenza drugs","volume":"7","author":"Feng","year":"2012","journal-title":"ChemMedChem"},{"issue":"7","key":"10.1016\/j.jhazmat.2024.135087_bib34","doi-asserted-by":"crossref","first-page":"459","DOI":"10.4155\/fmc-2022-0005","article-title":"Proteolysis targeting chimeras in antiviral research","volume":"14","author":"Desantis","year":"2022","journal-title":"Future Med Chem"},{"issue":"1","key":"10.1016\/j.jhazmat.2024.135087_bib35","doi-asserted-by":"crossref","first-page":"3468","DOI":"10.1038\/s41467-019-11429-w","article-title":"Small molecule degraders of the hepatitis C virus protease reduce susceptibility to resistance mutations","volume":"10","author":"de Wispelaere","year":"2019","journal-title":"Nat Commun"},{"issue":"10","key":"10.1016\/j.jhazmat.2024.135087_bib36","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1021\/acscentsci.0c00984","article-title":"Targeting the SARS-CoV-2 RNA genome with small molecule binders and ribonuclease targeting chimera (RIBOTAC) degraders","volume":"6","author":"Haniff","year":"2020","journal-title":"ACS Cent Sci"},{"issue":"36","key":"10.1016\/j.jhazmat.2024.135087_bib37","doi-asserted-by":"crossref","first-page":"9725","DOI":"10.1073\/pnas.1711463114","article-title":"Covalent inhibitors for eradication of drug-resistant HIV-1 reverse transcriptase: from design to protein crystallography","volume":"114","author":"Chan","year":"2017","journal-title":"Proc Natl Acad Sci"},{"issue":"36","key":"10.1016\/j.jhazmat.2024.135087_bib38","doi-asserted-by":"crossref","first-page":"15532","DOI":"10.1002\/anie.202004832","article-title":"Topology-matching design of an influenza-neutralizing spiky nanoparticle-based inhibitor with a dual mode of action","volume":"59","author":"Nie","year":"2020","journal-title":"Angew Chem Int Ed"},{"issue":"1","key":"10.1016\/j.jhazmat.2024.135087_bib39","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abd3803","article-title":"Heteromultivalent topology-matched nanostructures as potent and broad-spectrum influenza A virus inhibitors","volume":"7","author":"Nie","year":"2021","journal-title":"Sci Adv"},{"issue":"7","key":"10.1016\/j.jhazmat.2024.135087_bib40","doi-asserted-by":"crossref","first-page":"5367","DOI":"10.1021\/acs.nanolett.0c01723","article-title":"Spiky nanostructures with geometry-matching topography for virus inhibition","volume":"20","author":"Nie","year":"2020","journal-title":"Nano Lett"},{"issue":"5","key":"10.1016\/j.jhazmat.2024.135087_bib41","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1039\/C5CS00158G","article-title":"Simple bioconjugate chemistry serves great clinical advances: albumin as a versatile platform for diagnosis and precision therapy [10.1039\/C5CS00158G]","volume":"45","author":"Liu","year":"2016","journal-title":"Chem Soc Rev"},{"issue":"3","key":"10.1016\/j.jhazmat.2024.135087_bib42","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0032599","article-title":"Biophysical property and broad anti-HIV activity of albuvirtide, a 3-maleimimidopropionic acid-modified peptide fusion inhibitor","volume":"7","author":"Chong","year":"2012","journal-title":"PLoS One"},{"issue":"24","key":"10.1016\/j.jhazmat.2024.135087_bib43","doi-asserted-by":"crossref","DOI":"10.1097\/CM9.0000000000001273","article-title":"Efficacy and safety of the long-acting fusion inhibitor albuvirtide in antiretroviral-experienced adults with human immunodeficiency virus-1: interim analysis of the randomized, controlled, phase 3, non-inferiority TALENT study","volume":"133","author":"Su","year":"2020","journal-title":"Chin Med J"},{"issue":"25","key":"10.1016\/j.jhazmat.2024.135087_bib44","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abb0310","article-title":"Cytosolic delivery of proteins by cholesterol tagging","volume":"6","author":"Tai","year":"2020","journal-title":"Sci Adv"},{"issue":"23","key":"10.1016\/j.jhazmat.2024.135087_bib45","doi-asserted-by":"crossref","first-page":"17403","DOI":"10.1021\/acs.jmedchem.1c01531","article-title":"Zanamivir\u2013cholesterol conjugate: a long-acting neuraminidase inhibitor with potent efficacy against drug-resistant influenza viruses","volume":"64","author":"Lv","year":"2021","journal-title":"J Med Chem"},{"issue":"12","key":"10.1016\/j.jhazmat.2024.135087_bib46","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1038\/nrd2400","article-title":"The war against influenza: discovery and development of sialidase inhibitors","volume":"6","author":"von Itzstein","year":"2007","journal-title":"Nat Rev Drug Discov"},{"issue":"29","key":"10.1016\/j.jhazmat.2024.135087_bib47","doi-asserted-by":"crossref","first-page":"3847","DOI":"10.2174\/138161205774580642","article-title":"The antiviral activity, mechanism of action, clinical significance and resistance of abacavir in the treatment of pediatric AIDS","volume":"11","author":"Melroy","year":"2005","journal-title":"Curr Pharm Des"},{"issue":"5","key":"10.1016\/j.jhazmat.2024.135087_bib48","first-page":"275","article-title":"Acyclovir: mechanism of action, pharmacokinetics, safety and clinical applications","volume":"3","author":"Gnann Jr","year":"1983","journal-title":"Pharm: J Hum Pharmacol Drug Ther"},{"key":"10.1016\/j.jhazmat.2024.135087_bib49","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0213-005X(08)76547-9","article-title":"Caracter\u00edsticas qu\u00edmicas, mecanismo de acci\u00f3n y actividad antiviral de darunavir","volume":"26","author":"Pasquau Lia\u00f1o","year":"2008","journal-title":"Enferm Infecc Y Microbiol Cl\u00ednica"},{"key":"10.1016\/j.jhazmat.2024.135087_bib50","series-title":"xPharm: The Comprehensive Pharmacology Reference","first-page":"1","article-title":"Lamivudine","author":"Weston","year":"2007"},{"key":"10.1016\/j.jhazmat.2024.135087_bib51","series-title":"xPharm: The Comprehensive Pharmacology Reference","first-page":"1","article-title":"HIV nucleoside reverse transcriptase inhibitors","author":"Scholar","year":"2007"},{"key":"10.1016\/j.jhazmat.2024.135087_bib52","unstructured":"Edwards, Z., Ingold, C.J., & Azmat, C.E. (2023). Zidovudine. StatPearls Publishing, Treasure Island (FL). \u3008http:\/\/europepmc.org\/abstract\/MED\/32119306\u3009 \u3008http:\/\/europepmc.org\/books\/NBK554419\u3009 \u3008https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK554419\u3009."},{"issue":"5","key":"10.1016\/j.jhazmat.2024.135087_bib53","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1155\/S1064744998000404","article-title":"Zidovudine","volume":"6","author":"Sperling","year":"1998","journal-title":"Infect Dis Obstet Gynecol"},{"key":"10.1016\/j.jhazmat.2024.135087_bib54","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2016.00450","article-title":"Peramivir: a novel intravenous neuraminidase inhibitor for treatment of acute influenza infections [Review]","volume":"7","author":"Alame","year":"2016","journal-title":"Front Microbiol"},{"issue":"Suppl 1","key":"10.1016\/j.jhazmat.2024.135087_bib55","first-page":"119","article-title":"Antiviral beta-L-nucleosides specific for hepatitis B virus infection","volume":"12","author":"Standring","year":"2001","journal-title":"Antivir Chem Chemother"},{"key":"10.1016\/j.jhazmat.2024.135087_bib56","series-title":"Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases (Eighth Edition)","first-page":"531","article-title":"44 - Antiviral Drugs for Influenza and Other Respiratory Virus Infections","author":"Aoki","year":"2015"},{"issue":"12","key":"10.1016\/j.jhazmat.2024.135087_bib57","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.1128\/AAC.36.12.2747","article-title":"Mode of antiviral action of penciclovir in MRC-5 cells infected with herpes simplex virus type 1 (HSV-1), HSV-2, and varicella-zoster virus","volume":"36","author":"Earnshaw","year":"1992","journal-title":"Antimicrob Agents Chemother"},{"issue":"6","key":"10.1016\/j.jhazmat.2024.135087_bib58","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1093\/jac\/dkh244","article-title":"Pharmacokinetics of valaciclovir","volume":"53","author":"MacDougall","year":"2004","journal-title":"J Antimicrob Chemother"},{"issue":"6","key":"10.1016\/j.jhazmat.2024.135087_bib59","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1586\/14787210.6.6.785","article-title":"Atazanavir: its role in HIV treatment","volume":"6","author":"Wood","year":"2008","journal-title":"Expert Rev Anti-Infect Ther"},{"key":"10.1016\/j.jhazmat.2024.135087_bib60","doi-asserted-by":"crossref","first-page":"224","DOI":"10.4103\/0253-7613.178821","article-title":"Meyler's side effects of drugs: the international encyclopedia of adverse drug reactions and interactions","volume":"Vol. 48","author":"Desai","year":"2016","journal-title":"Indian J Pharm"},{"key":"10.1016\/j.jhazmat.2024.135087_bib61","unstructured":"Pollak, E.B., & Parmar, M. (2024). Indinavir. In StatPearls. StatPearls Publishing. Copyright \u00a9 2024, StatPearls Publishing LLC."},{"key":"10.1016\/j.jhazmat.2024.135087_bib62","series-title":"Encyclopedia of microbiology (Third Edition)","first-page":"223","article-title":"Antiviral agents","author":"Paintsil","year":"2009"},{"issue":"18","key":"10.1016\/j.jhazmat.2024.135087_bib63","doi-asserted-by":"crossref","first-page":"11687","DOI":"10.1093\/nar\/gku819","article-title":"Mechanism of allosteric inhibition of HIV-1 reverse transcriptase revealed by single-molecule and ensemble fluorescence","volume":"42","author":"Schauer","year":"2014","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.jhazmat.2024.135087_bib64","article-title":"A review and clinical understanding of tenofovir: tenofovir disoproxil fumarate versus tenofovir alafenamide","volume":"19","author":"Wassner","year":"2020","journal-title":"J Int Assoc Provid AIDS Care (JIAPAC)"},{"issue":"3","key":"10.1016\/j.jhazmat.2024.135087_bib65","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/2047-783X-14-S3-5","article-title":"Raltegravir: molecular basis of its mechanism of action","volume":"14","author":"Mouscadet","year":"2009","journal-title":"Eur J Med Res"},{"issue":"7","key":"10.1016\/j.jhazmat.2024.135087_bib66","doi-asserted-by":"crossref","DOI":"10.3390\/biom12070944","article-title":"Saquinavir: from HIV to COVID-19 and cancer treatment","volume":"12","author":"Pereira","year":"2022","journal-title":"Biomolecules"},{"issue":"1","key":"10.1016\/j.jhazmat.2024.135087_bib67","doi-asserted-by":"crossref","DOI":"10.3390\/biom13010088","article-title":"Efavirenz: history, development and future","volume":"13","author":"Costa","year":"2023","journal-title":"Biomolecules"},{"issue":"8","key":"10.1016\/j.jhazmat.2024.135087_bib68","doi-asserted-by":"crossref","first-page":"769","DOI":"10.2165\/00003495-200363080-00004","article-title":"Lopinavir\/Ritonavir","volume":"63","author":"Cvetkovic","year":"2003","journal-title":"Drugs"},{"issue":"10","key":"10.1016\/j.jhazmat.2024.135087_bib69","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1002249","article-title":"Structural and functional analysis of laninamivir and its octanoate prodrug reveals group specific mechanisms for influenza NA inhibition","volume":"7","author":"Vavricka","year":"2011","journal-title":"PLoS Pathog"},{"issue":"Supplement_3","key":"10.1016\/j.jhazmat.2024.135087_bib70","doi-asserted-by":"crossref","first-page":"S490","DOI":"10.1093\/clinids\/10.Supplement_3.S490","article-title":"Antiviral activity and mechanism of action of ganciclovir","volume":"10","author":"Matthews","year":"1988","journal-title":"Rev Infect Dis"},{"issue":"2","key":"10.1016\/j.jhazmat.2024.135087_bib71","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s00702-021-02306-2","article-title":"Amantadine: reappraisal of the timeless diamond\u2014target updates and novel therapeutic potentials","volume":"128","author":"Danysz","year":"2021","journal-title":"J Neural Transm"},{"issue":"suppl_2","key":"10.1016\/j.jhazmat.2024.135087_bib72","first-page":"ii5","article-title":"Pharmacokinetics of oseltamivir: an oral antiviral for the treatment and prophylaxis of influenza in diverse populations","volume":"65","author":"Davies","year":"2010","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jhazmat.2024.135087_bib73","series-title":"xPharm: The Comprehensive Pharmacology Reference","first-page":"1","article-title":"Famciclovir","author":"Mondal","year":"2007"},{"issue":"7","key":"10.1016\/j.jhazmat.2024.135087_bib74","doi-asserted-by":"crossref","first-page":"2484","DOI":"10.1073\/pnas.92.7.2484","article-title":"ABT-538 is a potent inhibitor of human immunodeficiency virus protease and has high oral bioavailability in humans","volume":"92","author":"Kempf","year":"1995","journal-title":"Proc Natl Acad Sci"},{"issue":"1","key":"10.1016\/j.jhazmat.2024.135087_bib75","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/s41467-020-20542-0","article-title":"Mechanism of SARS-CoV-2 polymerase stalling by remdesivir","volume":"12","author":"Kokic","year":"2021","journal-title":"Nat Commun"},{"issue":"4","key":"10.1016\/j.jhazmat.2024.135087_bib76","doi-asserted-by":"crossref","DOI":"10.1097\/COH.0000000000000168","article-title":"Formulation and pharmacology of long-acting cabotegravir","volume":"10","author":"Trezza","year":"2015","journal-title":"Curr Opin HIV AIDS"},{"issue":"3","key":"10.1016\/j.jhazmat.2024.135087_bib77","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.jpha.2022.10.005","article-title":"Advances and challenges in using nirmatrelvir and its derivatives against SARS-CoV-2 infection","volume":"13","author":"Chen","year":"2023","journal-title":"J Pharm Anal"},{"key":"10.1016\/j.jhazmat.2024.135087_bib78","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/j.chemosphere.2018.02.105","article-title":"LC-MS\/MS determination of antiretroviral drugs in influents and effluents from wastewater treatment plants in KwaZulu-Natal, South Africa","volume":"200","author":"Abafe","year":"2018","journal-title":"Chemosphere"},{"key":"10.1016\/j.jhazmat.2024.135087_bib79","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.marchem.2016.05.010","article-title":"Inputs and seasonal removal of pharmaceuticals in the estuarine Garonne River","volume":"185","author":"Aminot","year":"2016","journal-title":"Mar Chem"},{"key":"10.1016\/j.jhazmat.2024.135087_bib80","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.watres.2016.03.045","article-title":"Identification of transformation products of antiviral drugs formed during biological wastewater treatment and their occurrence in the urban water cycle","volume":"98","author":"Funke","year":"2016","journal-title":"Water Res"},{"key":"10.1016\/j.jhazmat.2024.135087_bib81","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.chemosphere.2015.12.135","article-title":"Occurrence of immunosuppressive drugs and their metabolites in the sewage-impacted Vistula and Utrata Rivers and in tap water from the Warsaw region (Poland)","volume":"148","author":"Giebu\u0142towicz","year":"2016","journal-title":"Chemosphere"},{"issue":"6","key":"10.1016\/j.jhazmat.2024.135087_bib82","doi-asserted-by":"crossref","first-page":"5788","DOI":"10.1007\/s11356-017-0861-x","article-title":"Occurrence of antimicrobial agents, drug-resistant bacteria, and genes in the sewage-impacted Vistula River (Poland)","volume":"25","author":"Giebu\u0142towicz","year":"2018","journal-title":"Environ Sci Pollut Res"},{"issue":"2","key":"10.1016\/j.jhazmat.2024.135087_bib83","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.marpolbul.2016.04.038","article-title":"The impact of onsite wastewater disposal systems on groundwater in areas inundated by Hurricane Sandy in New York and New Jersey","volume":"107","author":"Fisher","year":"2016","journal-title":"Mar Pollut Bull"},{"key":"10.1016\/j.jhazmat.2024.135087_bib84","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1016\/j.scitotenv.2016.03.128","article-title":"Nationwide reconnaissance of contaminants of emerging concern in source and treated drinking waters of the United States: pharmaceuticals","volume":"579","author":"Furlong","year":"2017","journal-title":"Sci Total Environ"},{"key":"10.1016\/j.jhazmat.2024.135087_bib85","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.chemosphere.2016.01.095","article-title":"Occurrence patterns of pharmaceutical residues in wastewater, surface water and groundwater of Nairobi and Kisumu city, Kenya","volume":"149","author":"K'Oreje","year":"2016","journal-title":"Chemosphere"},{"key":"10.1016\/j.jhazmat.2024.135087_bib86","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.scitotenv.2012.07.052","article-title":"From multi-residue screening to target analysis of pharmaceuticals in water: development of a new approach based on magnetic sector mass spectrometry and application in the Nairobi River basin, Kenya","volume":"437","author":"K'Oreje","year":"2012","journal-title":"Sci Total Environ"},{"key":"10.1016\/j.jhazmat.2024.135087_bib87","first-page":"263","article-title":"Chapter 9 - Application of orbitrap mass spectrometry for the identification of transformation products of trace organic contaminants formed in the environment","volume":"Vol. 71","author":"Prasse","year":"2016"},{"key":"10.1016\/j.jhazmat.2024.135087_bib88","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.envpol.2015.01.030","article-title":"The occurrence of anti-retroviral compounds used for HIV treatment in South African surface water","volume":"199","author":"Wood","year":"2015","journal-title":"Environ Pollut"},{"key":"10.1016\/j.jhazmat.2024.135087_bib89","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.chemosphere.2016.11.102","article-title":"Fate of new three anti-influenza drugs and one prodrug in the water environment","volume":"169","author":"Azuma","year":"2017","journal-title":"Chemosphere"},{"issue":"6","key":"10.1016\/j.jhazmat.2024.135087_bib90","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0131412","article-title":"Detection of peramivir and laninamivir, new anti-influenza drugs, in sewage effluent and river waters in Japan","volume":"10","author":"Azuma","year":"2015","journal-title":"PLoS One"},{"issue":"9","key":"10.1016\/j.jhazmat.2024.135087_bib91","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1080\/03067319.2014.921290","article-title":"Optimisation of the analysis of anti-influenza drugs in wastewater and surface water","volume":"94","author":"Azuma","year":"2014","journal-title":"Int J Environ Anal Chem"},{"issue":"1","key":"10.1016\/j.jhazmat.2024.135087_bib92","doi-asserted-by":"crossref","first-page":"57","DOI":"10.2965\/jwet.2012.57","article-title":"Antiviral drugs zanamivir and oseltamivir found in wastewater and surface water in Osaka, Japan","volume":"10","author":"Takanami","year":"2012","journal-title":"J Water Environ Technol"},{"key":"10.1016\/j.jhazmat.2024.135087_bib93","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.scitotenv.2018.11.433","article-title":"Environmental fate of pharmaceutical compounds and antimicrobial-resistant bacteria in hospital effluents, and contributions to pollutant loads in the surface waters in Japan","volume":"657","author":"Azuma","year":"2019","journal-title":"Sci Total Environ"},{"key":"10.1016\/j.jhazmat.2024.135087_bib94","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.chroma.2017.12.023","article-title":"Utilization of large volume zwitterionic hydrophilic interaction liquid chromatography for the analysis of polar pharmaceuticals in aqueous environmental samples: benefits and limitations","volume":"1535","author":"Boulard","year":"2018","journal-title":"J Chromatogr A"},{"key":"10.1016\/j.jhazmat.2024.135087_bib95","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1016\/j.scitotenv.2018.01.263","article-title":"Contaminants of emerging concern in the Hartbeespoort Dam catchment and the uMngeni River estuary 2016 pollution incident, South Africa","volume":"627","author":"Rimayi","year":"2018","journal-title":"Sci Total Environ"},{"issue":"1","key":"10.1016\/j.jhazmat.2024.135087_bib96","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1289\/ehp.0900930","article-title":"Oseltamivir carboxylate, the active metabolite of oseltamivir phosphate (tamiflu), detected in sewage discharge and river water in Japan","volume":"118","author":"Ghosh Gopal","year":"2010","journal-title":"Environ Health Perspect"},{"key":"10.1016\/j.jhazmat.2024.135087_bib97","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.envpol.2018.05.061","article-title":"Screening hundreds of emerging organic pollutants (EOPs) in surface water from the Yangtze River Delta (YRD): occurrence, distribution, ecological risk","volume":"241","author":"Peng","year":"2018","journal-title":"Environ Pollut"},{"issue":"9","key":"10.1016\/j.jhazmat.2024.135087_bib98","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0108621","article-title":"Intra- and inter-pandemic variations of antiviral, antibiotics and decongestants in wastewater treatment plants and receiving rivers","volume":"9","author":"Singer","year":"2014","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.jhazmat.2024.135087_bib99","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0006064","article-title":"Detection of the antiviral drug oseltamivir in aquatic environments","volume":"4","author":"S\u00f6derstr\u00f6m","year":"2009","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.jhazmat.2024.135087_bib100","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1007\/s11030-020-10134-x","article-title":"Therapeutics for COVID-19: from computation to practices\u2014where we are, where we are heading to","volume":"25","author":"Ojha","year":"2021","journal-title":"Mol Divers"},{"issue":"28","key":"10.1016\/j.jhazmat.2024.135087_bib101","doi-asserted-by":"crossref","first-page":"8585","DOI":"10.1007\/s00216-015-9017-3","article-title":"Development and application of a multi-residue method for the determination of 53 pharmaceuticals in water, sediment, and suspended solids using liquid chromatography-tandem mass spectrometry","volume":"407","author":"Aminot","year":"2015","journal-title":"Anal Bioanal Chem"},{"issue":"5","key":"10.1016\/j.jhazmat.2024.135087_bib102","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1021\/es903216p","article-title":"Antiviral drugs in wastewater and surface waters: a new pharmaceutical class of environmental relevance","volume":"44","author":"Prasse","year":"2010","journal-title":"Environ Sci Technol"},{"key":"10.1016\/j.jhazmat.2024.135087_bib103","doi-asserted-by":"crossref","DOI":"10.1016\/j.foodchem.2021.130874","article-title":"A critical review on the health benefits of fish consumption and its bioactive constituents","volume":"369","author":"Chen","year":"2022","journal-title":"Food Chem"},{"issue":"15","key":"10.1016\/j.jhazmat.2024.135087_bib104","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1001\/jama.296.15.1885","article-title":"Fish intake, contaminants, and human healthevaluating the risks and the benefits","volume":"296","author":"Mozaffarian","year":"2006","journal-title":"Jama"},{"key":"10.1016\/j.jhazmat.2024.135087_bib105","doi-asserted-by":"crossref","DOI":"10.1016\/j.fsi.2023.108977","article-title":"Immunotoxicity and transcriptome analysis of zebrafish embryos exposure to Nitazoxanide","volume":"141","author":"Lu","year":"2023","journal-title":"Fish Shellfish Immunol"},{"issue":"1","key":"10.1016\/j.jhazmat.2024.135087_bib106","doi-asserted-by":"crossref","first-page":"77","DOI":"10.2989\/16085914.2019.1571477","article-title":"Nevirapine in African surface waters induces liver histopathology in Oreochromis mossambicus: a laboratory exposure study","volume":"44","author":"Nibamureke","year":"2019","journal-title":"Afr J Aquat Sci"},{"key":"10.1016\/j.jhazmat.2024.135087_bib107","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2022.839166","article-title":"An EGFP knock-in zebrafish experimental model used in evaluation of the amantadine drug safety during early cardiogenesis [Original Research]","volume":"9","author":"Ouyang","year":"2022","journal-title":"Front Cardiovasc Med"},{"issue":"20","key":"10.1016\/j.jhazmat.2024.135087_bib108","doi-asserted-by":"crossref","first-page":"9740","DOI":"10.1111\/jcmm.16922","article-title":"Nitazoxanide induced myocardial injury in zebrafish embryos by activating oxidative stress response","volume":"25","author":"Gong","year":"2021","journal-title":"J Cell Mol Med"},{"key":"10.1016\/j.jhazmat.2024.135087_bib109","doi-asserted-by":"crossref","DOI":"10.1016\/j.scitotenv.2022.153967","article-title":"Revealing the toxicity of lopinavir- and ritonavir-containing water and wastewater treated by photo-induced processes to Danio rerio and Allivibrio fischeri","volume":"824","author":"Czech","year":"2022","journal-title":"Sci Total Environ"},{"issue":"4","key":"10.1016\/j.jhazmat.2024.135087_bib110","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1002\/bdr2.2128","article-title":"Developmental safety of nirmatrelvir in zebrafish (Danio rerio) embryos","volume":"115","author":"Zizioli","year":"2023","journal-title":"Birth Defects Res"},{"issue":"3","key":"10.1016\/j.jhazmat.2024.135087_bib111","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.3390\/ijms24031994","article-title":"Cabotegravir exposure of zebrafish (Danio rerio) embryos impacts on neurodevelopment and behavior","volume":"24","author":"Zizioli","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jhazmat.2024.135087_bib112","doi-asserted-by":"crossref","DOI":"10.1016\/j.taap.2020.115334","article-title":"Famciclovir leads to failure of hematopoiesis, but may have the benefit of relieving myeloid expansion in MDS-like zebrafish","volume":"410","author":"Li","year":"2021","journal-title":"Toxicol Appl Pharmacol"},{"issue":"10","key":"10.1016\/j.jhazmat.2024.135087_bib113","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1002\/jat.4336","article-title":"The mechanism and effects of remdesivir-induced developmental toxicity in zebrafish: Blood flow dysfunction and behavioral alterations","volume":"42","author":"Li","year":"2022","journal-title":"J Appl Toxicol"},{"key":"10.1016\/j.jhazmat.2024.135087_bib114","doi-asserted-by":"crossref","DOI":"10.1016\/j.scitotenv.2023.164484","article-title":"Toxicological evaluation of antiretroviral Tenofovir Disoproxil Fumarate on the mollusk Biomphalaria glabrata and its hemocytes","volume":"891","author":"Souza-Silva","year":"2023","journal-title":"Sci Total Environ"},{"key":"10.1016\/j.jhazmat.2024.135087_bib115","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.etap.2017.09.017","article-title":"The potential effects of efavirenz on Oreochromis mossambicus after acute exposure","volume":"56","author":"Robson","year":"2017","journal-title":"Environ Toxicol Pharmacol"},{"issue":"3","key":"10.1016\/j.jhazmat.2024.135087_bib116","doi-asserted-by":"crossref","first-page":"226","DOI":"10.3390\/toxics11030226","article-title":"Amantadine toxicity in apostichopus japonicus revealed by proteomics","volume":"11","author":"Zhao","year":"2023","journal-title":"Toxics"},{"issue":"4","key":"10.1016\/j.jhazmat.2024.135087_bib117","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/j.jhep.2013.06.005","article-title":"ER stress in human hepatic cells treated with Efavirenz: mitochondria again","volume":"59","author":"Apostolova","year":"2013","journal-title":"J Hepatol"},{"issue":"1","key":"10.1016\/j.jhazmat.2024.135087_bib118","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1002\/hep.23647","article-title":"Inhibition of mitochondrial function by efavirenz increases lipid content in hepatic cells","volume":"52","author":"Blas-Garc\u00eda","year":"2010","journal-title":"Hepatology"},{"issue":"14","key":"10.1016\/j.jhazmat.2024.135087_bib119","doi-asserted-by":"crossref","first-page":"11664","DOI":"10.3390\/ijms241411664","article-title":"Comparison of efavirenz and doravirine developmental toxicity in an embryo animal model","volume":"24","author":"Zizioli","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"6","key":"10.1016\/j.jhazmat.2024.135087_bib120","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1085\/jgp.201210771","article-title":"What comes first, misshape or dysfunction? The view from metabolic excess","volume":"139","author":"Galloway","year":"2012","journal-title":"J Gen Physiol"},{"issue":"1","key":"10.1016\/j.jhazmat.2024.135087_bib121","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/s00204-017-2063-1","article-title":"Usefulness of zebrafish larvae to evaluate drug-induced functional and morphological renal tubular alterations","volume":"92","author":"Gorgulho","year":"2018","journal-title":"Arch Toxicol"},{"issue":"1","key":"10.1016\/j.jhazmat.2024.135087_bib122","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1006\/dbio.2002.0820","article-title":"Neurogenin1 Defines Zebrafish Cranial Sensory Ganglia Precursors","volume":"251","author":"Andermann","year":"2002","journal-title":"Dev Biol"},{"issue":"13","key":"10.1016\/j.jhazmat.2024.135087_bib123","doi-asserted-by":"crossref","first-page":"5143","DOI":"10.1073\/pnas.0600337103","article-title":"Neurogenin1 is a determinant of zebrafish basal forebrain dopaminergic neurons and is regulated by the conserved zinc finger protein Tof\/Fezl","volume":"103","author":"Jeong","year":"2006","journal-title":"Proc Natl Acad Sci"},{"issue":"1","key":"10.1016\/j.jhazmat.2024.135087_bib124","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1002\/(SICI)1097-0177(199809)213:1<92::AID-AJA9>3.0.CO;2-T","article-title":"Expression of zebrafish bHLH genes ngn1and nrd defines distinct stages of neural differentiation","volume":"213","author":"Korzh","year":"1998","journal-title":"Dev Dyn"},{"key":"10.1016\/j.jhazmat.2024.135087_bib125","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.neuro.2020.03.013","article-title":"Fenobucarb-induced developmental neurotoxicity and mechanisms in zebrafish","volume":"79","author":"Zhu","year":"2020","journal-title":"NeuroToxicology"},{"key":"10.1016\/j.jhazmat.2024.135087_bib126","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.ejphar.2017.02.009","article-title":"HIV antiretroviral drug Efavirenz induces anxiety-like and depression-like behavior in rats: evaluation of neurotransmitter alterations in the striatum","volume":"799","author":"Cavalcante","year":"2017","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.jhazmat.2024.135087_bib127","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.emcon.2022.02.001","article-title":"Developmental abnormalities and growth patterns in juvenile Oreochromis mossambicus chronically exposed to efavirenz","volume":"8","author":"Kowlaser","year":"2022","journal-title":"Emerg Contam"},{"key":"10.1016\/j.jhazmat.2024.135087_bib128","doi-asserted-by":"crossref","DOI":"10.1016\/j.envpol.2020.114146","article-title":"Impact of long-term parental exposure to Tamiflu metabolites on the development medaka offspring (Oryzias latipes)","volume":"261","author":"Chen","year":"2020","journal-title":"Environ Pollut"},{"issue":"1","key":"10.1016\/j.jhazmat.2024.135087_bib129","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-43911-3","article-title":"Identification of side effects of COVID-19 drug candidates on embryogenesis using an integrated zebrafish screening platform","volume":"13","author":"Ernst","year":"2023","journal-title":"Sci Rep"},{"issue":"6","key":"10.1016\/j.jhazmat.2024.135087_bib130","doi-asserted-by":"crossref","first-page":"3100","DOI":"10.1021\/es4047507","article-title":"Principles of sound ecotoxicology","volume":"48","author":"Harris","year":"2014","journal-title":"Environ Sci Technol"},{"key":"10.1016\/j.jhazmat.2024.135087_bib131","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1016\/j.scitotenv.2017.05.039","article-title":"An alternative approach to risk rank chemicals on the threat they pose to the aquatic environment","volume":"599\u2013600","author":"Johnson","year":"2017","journal-title":"Sci Total Environ"},{"key":"10.1016\/j.jhazmat.2024.135087_bib132","article-title":"Pharmaceuticals in the aquatic environment: no answers yet to the major questions","author":"Sumpter","year":"2022","journal-title":"Environ Toxicol Chem"},{"key":"10.1016\/j.jhazmat.2024.135087_bib133","doi-asserted-by":"crossref","DOI":"10.1016\/j.scitotenv.2021.148617","article-title":"A comprehensive aquatic risk assessment of the beta-blocker propranolol, based on the results of over 600 research papers","volume":"793","author":"Sumpter","year":"2021","journal-title":"Sci Total Environ"},{"key":"10.1016\/j.jhazmat.2024.135087_bib134","doi-asserted-by":"crossref","DOI":"10.1016\/j.chemosphere.2021.133250","article-title":"In silico analytical toolset for predictive degradation and toxicity of hazardous pollutants in water sources","volume":"292","author":"Singh","year":"2022","journal-title":"Chemosphere"},{"key":"10.1016\/j.jhazmat.2024.135087_bib135","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.compbiomed.2013.11.013","article-title":"Comprehension of drug toxicity: software and databases","volume":"45","author":"Toropov","year":"2014","journal-title":"Comput Biol Med"},{"key":"10.1016\/j.jhazmat.2024.135087_bib136","unstructured":"ECB, E.C.B. (2003). Technical guidance document on risk assessment: Part II Office for Official Publications of the European Communities. \u3008https:\/\/hero.epa.gov\/hero\/index.cfm\/reference\/details\/reference_id\/196375\u3009."},{"issue":"W1","key":"10.1016\/j.jhazmat.2024.135087_bib137","doi-asserted-by":"crossref","first-page":"W257","DOI":"10.1093\/nar\/gky318","article-title":"ProTox-II: a webserver for the prediction of toxicity of chemicals","volume":"46","author":"Banerjee","year":"2018","journal-title":"Nucleic Acids Res"},{"issue":"12","key":"10.1016\/j.jhazmat.2024.135087_bib138","doi-asserted-by":"crossref","first-page":"629","DOI":"10.3390\/md18120629","article-title":"Mycotoxin identification and in silico toxicity assessment prediction in atlantic salmon","volume":"18","author":"Tolosa","year":"2020","journal-title":"Mar Drugs"},{"issue":"3","key":"10.1016\/j.jhazmat.2024.135087_bib139","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.yrtph.2014.04.006","article-title":"Ecological risk assessment of the presence of pharmaceutical residues in a French national water survey","volume":"69","author":"Bouissou-Schurtz","year":"2014","journal-title":"Regul Toxicol Pharmacol"},{"key":"10.1016\/j.jhazmat.2024.135087_bib140","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.jhazmat.2018.07.099","article-title":"Risk assessment of a mixture of emerging contaminants in surface water in a highly urbanized area in Italy","volume":"361","author":"Riva","year":"2019","journal-title":"J Hazard Mater"},{"issue":"Suppl 1","key":"10.1016\/j.jhazmat.2024.135087_bib141","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1289\/ehp.9358","article-title":"Low-level exposure to multiple chemicals: reason for human health concerns","volume":"115","author":"Kortenkamp","year":"2007","journal-title":"Environ Health Perspect"},{"issue":"3","key":"10.1016\/j.jhazmat.2024.135087_bib142","first-page":"203","article-title":"History of EPI Suite\u2122 and future perspectives on chemical property estimation in US Toxic Substances Control Act new chemical risk assessments [10.1039\/C7EM00064B]","volume":"19","author":"Card","year":"2017","journal-title":"Environ Sci: Process Impacts"},{"issue":"4","key":"10.1016\/j.jhazmat.2024.135087_bib143","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1021\/acs.jced.9b01129","article-title":"Experimental determination of octanol\u2013water partition coefficients of selected natural toxins","volume":"65","author":"Sch\u00f6nsee","year":"2020","journal-title":"J Chem Eng Data"},{"issue":"26","key":"10.1016\/j.jhazmat.2024.135087_bib144","doi-asserted-by":"crossref","first-page":"68987","DOI":"10.1007\/s11356-023-26899-1","article-title":"3,4-Dioxygenated xanthones as antifouling additives for marine coatings: in silico studies, seawater solubility, degradability, leaching, and antifouling performance","volume":"30","author":"Vilas-Boas","year":"2023","journal-title":"Environ Sci Pollut Res"},{"issue":"11","key":"10.1016\/j.jhazmat.2024.135087_bib145","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1007\/s10661-020-08661-z","article-title":"Assessment on biodegradability prediction of tannery wastewater using EPI Suite BIOWIN model","volume":"192","author":"Balakrishnan","year":"2020","journal-title":"Environ Monit Assess"},{"key":"10.1016\/j.jhazmat.2024.135087_bib146","unstructured":"Mikulic. M., (12th June, 2020). Global anti-viral market size 2019 and 2027 forecast. Statista. \u3008https:\/\/www.statista.com\/statistics\/1118674\/anti-viral-market-size-worldwide\/\u3009."},{"key":"10.1016\/j.jhazmat.2024.135087_bib147","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhazmat.2020.122589","article-title":"Enantiomer-specific bioaccumulation and distribution of chiral pharmaceuticals in a subtropical marine food web","volume":"394","author":"Ruan","year":"2020","journal-title":"J Hazard Mater"},{"key":"10.1016\/j.jhazmat.2024.135087_bib148","doi-asserted-by":"crossref","DOI":"10.1016\/j.cscee.2021.100079","article-title":"Microplastics as vectors of pharmaceuticals in aquatic organisms \u2013 An overview of their environmental implications","volume":"3","author":"Santos","year":"2021","journal-title":"Case Stud Chem Environ Eng"},{"issue":"7","key":"10.1016\/j.jhazmat.2024.135087_bib149","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1007\/s40264-013-0049-3","article-title":"Implementing ecopharmacovigilance in practice: challenges and potential opportunities","volume":"36","author":"Holm","year":"2013","journal-title":"Drug Saf"},{"key":"10.1016\/j.jhazmat.2024.135087_bib150","doi-asserted-by":"crossref","DOI":"10.1016\/j.etap.2020.103565","article-title":"Targeted eco-pharmacovigilance as an optimized management strategy for adverse effects of pharmaceuticals in the environment","volume":"82","author":"Wang","year":"2021","journal-title":"Environ Toxicol Pharmacol"},{"key":"10.1016\/j.jhazmat.2024.135087_bib151","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.etap.2018.05.020","article-title":"Adapting and applying common methods used in pharmacovigilance to the environment: A possible starting point for the implementation of eco-pharmacovigilance","volume":"61","author":"Wang","year":"2018","journal-title":"Environ Toxicol Pharmacol"},{"key":"10.1016\/j.jhazmat.2024.135087_bib152","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.desal.2004.06.113","article-title":"Developments in wastewater treatment methods","volume":"167","author":"Sonune","year":"2004","journal-title":"Desalination"},{"key":"10.1016\/j.jhazmat.2024.135087_bib153","doi-asserted-by":"crossref","DOI":"10.1016\/j.jclepro.2023.138008","article-title":"Optimization and control strategies of aeration in WWTPs: a review","volume":"418","author":"Gu","year":"2023","journal-title":"J Clean Prod"},{"key":"10.1016\/j.jhazmat.2024.135087_bib154","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.watres.2016.10.046","article-title":"Evaluation of a membrane bioreactor system as post-treatment in waste water treatment for better removal of micropollutants","volume":"107","author":"Arriaga","year":"2016","journal-title":"Water Res"},{"issue":"8","key":"10.1016\/j.jhazmat.2024.135087_bib155","doi-asserted-by":"crossref","first-page":"2585","DOI":"10.1016\/j.biortech.2009.10.057","article-title":"Biodegradability of pharmaceutical industrial wastewater and formation of recalcitrant organic compounds during aerobic biological treatment","volume":"101","author":"Mascolo","year":"2010","journal-title":"Bioresour Technol"},{"issue":"4","key":"10.1016\/j.jhazmat.2024.135087_bib156","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1007\/s10311-020-01014-9","article-title":"Photoelectrochemical reactors for treatment of water and wastewater: a review","volume":"18","author":"Mousset","year":"2020","journal-title":"Environ Chem Lett"},{"key":"10.1016\/j.jhazmat.2024.135087_bib157","doi-asserted-by":"crossref","DOI":"10.1016\/j.jenvman.2022.115523","article-title":"Antiviral drugs against influenza: treatment methods, environmental risk assessment and analytical determination","volume":"318","author":"Eryildiz","year":"2022","journal-title":"J Environ Manag"},{"issue":"1","key":"10.1016\/j.jhazmat.2024.135087_bib158","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.chemosphere.2010.07.023","article-title":"Occurrence and fate of oseltamivir carboxylate (Tamiflu) and amantadine in sewage treatment plants","volume":"81","author":"Ghosh","year":"2010","journal-title":"Chemosphere"},{"issue":"21","key":"10.1016\/j.jhazmat.2024.135087_bib159","doi-asserted-by":"crossref","first-page":"12725","DOI":"10.1021\/acs.jmedchem.0c01063","article-title":"Discovery of ketone-based covalent inhibitors of coronavirus 3CL proteases for the potential therapeutic treatment of COVID-19","volume":"63","author":"Hoffman","year":"2020","journal-title":"J Med Chem"},{"key":"10.1016\/j.jhazmat.2024.135087_bib160","doi-asserted-by":"crossref","DOI":"10.1016\/j.jwpe.2020.101855","article-title":"Occurrence of acyclovir in the aquatic environment, its removal and research perspectives: A review","volume":"39","author":"Gupta","year":"2021","journal-title":"J Water Process Eng"},{"issue":"4","key":"10.1016\/j.jhazmat.2024.135087_bib161","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1111\/wej.12612","article-title":"Removal of selected antibiotics and antiretroviral drugs during post-treatment of municipal wastewater with UV, UV\/chlorine and UV\/hydrogen peroxide","volume":"34","author":"Ngumba","year":"2020","journal-title":"Water Environ J"},{"key":"10.1016\/j.jhazmat.2024.135087_bib162","doi-asserted-by":"crossref","DOI":"10.1016\/j.scitotenv.2022.157256","article-title":"Renewing and improving the environmental risk assessment of chemicals","volume":"845","author":"Sumpter","year":"2022","journal-title":"Sci Total Environ"}],"container-title":["Journal of Hazardous Materials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304389424016662?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304389424016662?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,15]],"date-time":"2025-03-15T10:11:48Z","timestamp":1742033508000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304389424016662"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":162,"alternative-id":["S0304389424016662"],"URL":"https:\/\/doi.org\/10.1016\/j.jhazmat.2024.135087","relation":{},"ISSN":["0304-3894"],"issn-type":[{"value":"0304-3894","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hazards of antiviral contamination in water: Dissemination, fate, risk and their impact on fish","name":"articletitle","label":"Article Title"},{"value":"Journal of Hazardous Materials","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhazmat.2024.135087","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"135087"}}